Using Partners to Enhance Long-Term Weight Loss

NCT ID: NCT03801174

Last Updated: 2024-06-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

346 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-15

Study Completion Date

2023-03-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study involves an evaluation of the role of domestic partner support in a comprehensive weight loss initiation and maintenance program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Couples will be randomized to a comprehensive weight program directed at patients alone or involving their partners. In months 1-6, all patients will receive group-based weight loss program. In months 7-18, all patients will receive a telephone-based weight loss maintenance intervention. In the partner-assisted arm only, partners will participate in the intervention, learning and practicing communication skills and support strategies. In months 19-24, intervention will be withdrawn to examine sustainability of effects.

Due to COVID-19, option of doing screening and outcome assessment visits and attending the group classes (including exercise) remotely via a video conference may be available. COVID-19 survey will be administered every 3 month starting at screening/enrollment visit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Partner-assisted intervention

Patients and partners will receive intervention

Group Type EXPERIMENTAL

Partner-assisted intervention

Intervention Type BEHAVIORAL

All patients will receive group-based weight loss program for 6 months featuring a calorie-restricted diet and physical activity. Then, all patients will receive a weight loss maintenance intervention for 12 months that involves maintenance-specific content, transitions to individual telephone calls, and decreases frequency of contact. Partners will attend some patient group sessions and be informed of patients' goals and relapse plans. Intervention will be withdrawn for the last 6 months to examine sustainability of effects.

Patient-only intervention

Patients will receive intervention

Group Type ACTIVE_COMPARATOR

Patient-only intervention

Intervention Type BEHAVIORAL

All patients will receive group-based weight loss program for 6 months featuring a calorie-restricted diet and physical activity. Then, all patients will receive a weight loss maintenance intervention for 12 months that involves maintenance-specific content, transitions to individual telephone calls, and decreases frequency of contact. Intervention will be withdrawn for the last 6 months to examine sustainability of effects.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Partner-assisted intervention

All patients will receive group-based weight loss program for 6 months featuring a calorie-restricted diet and physical activity. Then, all patients will receive a weight loss maintenance intervention for 12 months that involves maintenance-specific content, transitions to individual telephone calls, and decreases frequency of contact. Partners will attend some patient group sessions and be informed of patients' goals and relapse plans. Intervention will be withdrawn for the last 6 months to examine sustainability of effects.

Intervention Type BEHAVIORAL

Patient-only intervention

All patients will receive group-based weight loss program for 6 months featuring a calorie-restricted diet and physical activity. Then, all patients will receive a weight loss maintenance intervention for 12 months that involves maintenance-specific content, transitions to individual telephone calls, and decreases frequency of contact. Intervention will be withdrawn for the last 6 months to examine sustainability of effects.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18-74 years
* BMI 27-29.9 kg/m2 plus at least one obesity-related comorbidity or BMI \>=30 kg/m2
* Cohabitating and at least daily contact with a spouse/domestic partner
* Access to reliable transportation
* Desire to lose weight
* Speak and read English
* Agree to attend visits per protocol
* Score of at least 4 out of 6 on Callahan cognitive screener
* Able to stand without assistance for weight measurements without assistance
* Possess individual email address
* Possess individual smart phone with data and texting plan
* Able to complete online screener without assistance
* Able to use a smartphone, tablet or computer with a video camera or webcam and microphone to download apps and to connect to a video conference call without assistance


* Aged 18 or older
* Willing to participate
* Access to reliable transportation
* Speak and read English
* Score of at least 4 out of 6 on Callahan cognitive screener
* Possess smart phone with data and texting plan (not shared with index patient)
* Possess email address (not shared with index patient)
* Able to complete online screener without assistance

Exclusion Criteria

* Currently or planning to become pregnant or breastfeeding in the study timeframe
* Weight loss ≥ 5 lb in the month prior to screening
* Currently enrolled, or enrolled in previous 3 months, in a clinical or research program focusing on lifestyle change that could affect weight
* Significant dementia, schizophrenia, psychosis, or drug or alcohol abuse
* Chronic or unstable illness that would limit ability to participate (e.g., recent hospitalization; unstable heart disease in the 6 months prior to screening, chronic kidney disease stage 4 or higher)
* Living a nursing home or receiving visits from a home health care agency
* Planning to relocate in the next 2.5 years
* Current use of prescription or over-the-counter weight loss medications
* History of bariatric surgery or planning to have bariatric surgery in the study timeframe
* Impaired hearing
* Currently receiving, or received in the past 6 months, treatment for cancer other than skin cancer
* Use of insulin, sulfonylureas, or meglinitides for diabetes
* High diuretic dose
* Exertional chest pain, dizziness, or lightheadedness
* Pain or other condition than prohibits mild-moderate exercise
* History of ascites requiring paracentesis


* BMI \<18.5 kg/m2
* Significant dementia, schizophrenia, psychosis, or drug or alcohol abuse
* Residing in a nursing home or receiving home health care
* Impaired hearing
* Currently receiving, or received in the past 6 months, treatment for cancer other than skin cancer
* Chronic or unstable illness that would limit ability to participate (e.g., recent hospitalization; unstable heart disease in the 6 months prior to screening)
Minimum Eligible Age

18 Years

Maximum Eligible Age

74 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Duke University

OTHER

Sponsor Role collaborator

RTI International

OTHER

Sponsor Role collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Corrine Voils, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Wisconsin-Madison

Madison, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Voils CI, Shaw RJ, Gavin KL, Hetzel SJ, Lewis MA, Pabich S, Johnson HM, Elwert F, Mao L, Gray KE, Yuroff A, Garza K, Yancy WS Jr, Porter LS. Outcomes from Partner2Lose: a randomized controlled trial to evaluate 24-month weight loss in a partner-assisted intervention. BMC Public Health. 2024 Jul 20;24(1):1948. doi: 10.1186/s12889-024-19464-z.

Reference Type DERIVED
PMID: 39033273 (View on PubMed)

Voils C, Shaw R, Gavin K, Hetzel S, Lewis M, Pabich S, Johnson H, Elwert F, Mao L, Gray K, Yuroff A, Garza K, Yancy W, Porter L. Primary outcomes from Partner2Lose: A randomized controlled trial to evaluate partner involvement on long-term weight loss. Res Sq [Preprint]. 2024 Mar 11:rs.3.rs-4001003. doi: 10.21203/rs.3.rs-4001003/v1.

Reference Type DERIVED
PMID: 38559225 (View on PubMed)

Miller HN, Voils CI, Cronin KA, Jeanes E, Hawley J, Porter LS, Adler RR, Sharp W, Pabich S, Gavin KL, Lewis MA, Johnson HM, Yancy WS Jr, Gray KE, Shaw RJ. A Method to Deliver Automated and Tailored Intervention Content: 24-month Clinical Trial. JMIR Form Res. 2022 Sep 6;6(9):e38262. doi: 10.2196/38262.

Reference Type DERIVED
PMID: 36066936 (View on PubMed)

Voils CI, Shaw R, Adler R, Jeanes E, Lewis MA, Sharp W, Cronin KA, Hetzel S, Mao L, Johnson HM, Elwert F, Pabich S, Gavin KL, Yancy WS Jr, Porter LS. Protocol for Partner2Lose: A randomized controlled trial to evaluate partner involvement on long-term weight loss. Contemp Clin Trials. 2020 Sep;96:106092. doi: 10.1016/j.cct.2020.106092. Epub 2020 Aug 1.

Reference Type DERIVED
PMID: 32750431 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Related Links

Access external resources that provide additional context or updates about the study.

http://www.partner2lose.com

Partner2Lose website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01DK111491-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

A539722

Identifier Type: OTHER

Identifier Source: secondary_id

SMPH/SURGERY

Identifier Type: OTHER

Identifier Source: secondary_id

2018-1400-CP028

Identifier Type: OTHER

Identifier Source: secondary_id

2018-1400

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Leader Partner Interactions
NCT02048774 COMPLETED NA
Dose-Response of Exercise on Long-Term Weight Loss
NCT00177762 COMPLETED PHASE1/PHASE2
Effect of Exercise on Prevention of Weight Gain
NCT00177502 COMPLETED PHASE1/PHASE2